HITM HEPATIC IMMUNOTHERAPY FOR METASTASES
Mark Identification

HITM HEPATIC IMMUNOTHERAPY FOR METASTASES

Serial Number

85393437

Filing Date

Aug 9, 2011

Registration Date

Jul 31, 2012

Trademark by

PROSPECT CHARTERCARE LLC

Classification Information

Medical services, namely, human cancer treatment involving the administration of genetically modified patient T cells delivered regionally, directly into the liver

Medical, Beauty & Agricultural